Slow and Study: Support for a Randomized Trial of β-Blockade in Sepsis-Associated Atrial Fibrillation
Chest
.
2016 Jan;149(1):9-10.
doi: 10.1016/j.chest.2015.08.020.
Epub 2016 Jan 6.
Authors
Matthew W Semler
1
,
Arthur P Wheeler
2
Affiliations
1
Vanderbilt University Medical Center, Nashville, TN. Electronic address: matthew.w.semler@vanderbilt.edu.
2
Vanderbilt University Medical Center, Nashville, TN.
PMID:
26757282
DOI:
10.1016/j.chest.2015.08.020
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anti-Arrhythmia Agents / therapeutic use*
Atrial Fibrillation / complications*
Atrial Fibrillation / drug therapy*
Female
Humans
Male
Sepsis / complications*
Substances
Anti-Arrhythmia Agents
Grants and funding
T32 HL087738/HL/NHLBI NIH HHS/United States